DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

IGIL vs SICAGEN: Stock Comparison

INTL GEMOLOGICAL INST vs SICAGEN INDIAUpdated 6 Nov 26, 4:08 PM ISTNSE & company filings

INTL GEMOLOGICAL INST is the larger company by market capitalisation. INTL GEMOLOGICAL INST shows a higher ROE, faster revenue growth and lower leverage, while SICAGEN INDIA shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

IGIL leads 9; SICAGEN leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

IGILSICAGEN

Valuation lens

What price are you paying?

Market CapContext only
₹17,667 Cr
₹218 Cr
P/E RatioSICAGEN has the lower reading
26.55x
11.41x ✓
P/B RatioSICAGEN has the lower reading
10.09x
0.47x ✓
EPSIGIL has the higher reading
₹4.3 ✓
₹1.75
Book ValueContext only
₹32.62
₹125.09
Dividend YieldSICAGEN has the higher reading
1.24%
1.81% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
IGIL is the larger company
₹17,667 Cr vs ₹218 Cr
P/E Ratio
SICAGEN has a lower P/E
11.41x vs 26.55x
P/B Ratio
SICAGEN has a lower P/B
0.47x vs 10.09x
EPS
IGIL has higher earnings per share
₹4.3 vs ₹1.75
Dividend Yield
SICAGEN has a higher dividend yield
1.81% vs 1.24%
Revenue Growth (TTM YoY)
IGIL has faster revenue growth
20.9% vs 0%
EPS Growth (TTM YoY)
IGIL has faster EPS growth
28.4% vs 0%
Qtr Sales Growth
IGIL has stronger quarterly sales growth
7.35% vs 2.9%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricIGILSICAGEN
SectorServices—
IndustryDiversified Commercial Services—

Price

MetricIGILSICAGEN
Live Price₹407.4₹55.28
Day Change0.11%-3.15%
Volume10.24 L11,971
52-Week High₹420.6₹74.06
52-Week Low₹287₹46.55
Distance from 52W High-3.14%-25.36%

Valuation

MetricIGILSICAGEN
Market Cap₹17,667 Cr₹218 Cr
P/E Ratio26.55x11.41x
P/B Ratio10.09x0.47x
EPS₹4.3₹1.75
Book Value₹32.62₹125.09
Dividend Yield1.24%1.81%

Growth

MetricIGILSICAGEN
Revenue Growth (TTM YoY)20.9%0%
EPS Growth (TTM YoY)28.4%0%
Qtr Sales Growth7.35%2.9%
Qtr Profit Growth12.13%55.38%

Profitability & Leverage

MetricIGILSICAGEN
ROE23.06%3.65%
ROCE23.33%4.43%
Net Margin46.09%1.86%
Operating Margin76.29%3.9%
Debt to Equity0x0.29x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricIGILSICAGEN
Promoter Holding76.55%23.92%
FII Holding8.8%▼ 0.69 pp2.47%
DII Holding5.47%▼ 0.04 pp0.58%
Public Holding9.18%▲ 0.73 pp35.81%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INTL GEMOLOGICAL INST and SICAGEN INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.